[1]
Pagliaro, A. et al. 2024. Psychiatric symptoms in patients with metastatic ALK-positive NSCLC treated with third-generation ALK-inhibitors: a brief review and case series. Journal of Medical Science. 93, 3 (Sep. 2024), e986. DOI:https://doi.org/10.20883/medical.e986.